Who owns the OMGEVI trademark?

The OMGEVI trademark is owned by Theravance Biopharma Ireland Limited.

What class is the OMGEVI trademark registered in?

The OMGEVI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OMGEVI?

The USPTO serial number for OMGEVI is 79305348.

What is the registration number for OMGEVI?

OMGEVI is registered under USPTO registration number 6624375.

Sealvo

Home Search: OMGEVIOMGEVI #79305348

Back

Updated Oct 6, 2026·22 searches this week

View on USPTO TSDR Find similar marks

OMG

USPTO Trademark Record

REGISTERED

OMGEVI

SN 79305348·Reg 6624375·Filed Dec 30, 2020

Owner Theravance Biopharma Ireland Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OMGEVI (Serial No. 79305348), Registration No. 6624375, is a registered US trademark filed on Dec 30, 2020 by Theravance Biopharma Ireland Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: January 25, 2028

Mark Intelligence

OMGEVI (Reg. #6624375) is a registered US trademark that has been protecting its owner, Theravance Biopharma Ireland Limited, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 30, 2020

SERIAL

79305348

REG#

6624375

REGISTERED

Jan 25, 2022

Filing Information

StatusREGISTERED

Filing DateDec 30, 2020

Serial Number79305348

Registration No.6624375

Registration DateJan 25, 2022

Status DateJan 25, 2022

Published for OppositionNov 09, 2021

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jul 23, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 01, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jul 07, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jul 07, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 25, 2022

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jan 25, 2022

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Nov 09, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 09, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 20, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 04, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 01, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 01, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 01, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Aug 15, 2021

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jul 28, 2021

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 28, 2021

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 19, 2021

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jul 18, 2021

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jul 03, 2021

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Mar 09, 2021

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 05, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 04, 2021

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Theravance Biopharma Ireland Limited

Additional USPTO filings from the same owner.

THE

THERAVANCE BIOPHARMA

79260681

Theravance Biopharma Ireland Limited

REGISTERED

LOG

LogoMark

79323261

Theravance Biopharma Ireland Limited

REGISTERED

UPI

UPIQLA

90570533

THERAVANCE BIOPHARMA IRELAND LIMITED

REGISTERED

HEV

HEVDUA

79305397

Theravance Biopharma Ireland Limited

REGISTERED

Other Marks by Beth H. Alter

Additional USPTO filings handled by the same attorney of record.

BYR

BYREFORGE

99263834

REGISTERED

HAC

HACC

99676602

REGISTERED

THE

THERAVANCE BIOPHARMA

79260681

REGISTERED

UNI

UNIFI ASSET MANAGEMENT

98571215

REGISTERED

OMGEVI

Run a conflict check

Other Marks by Theravance Biopharma Ireland Limited

Other Marks by Beth H. Alter

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company